Cargando…

Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review

BACKGROUND AND OBJECTIVE: This narrative review discusses Barrett’s esophagus management in the context of perceived deficiencies or controversies. Barrett’s adenocarcinoma incidence has not clearly been impacted by Barrett’s screening and surveillance. METHODS: The following report was derived from...

Descripción completa

Detalles Bibliográficos
Autor principal: Friedel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432233/
https://www.ncbi.nlm.nih.gov/pubmed/37601742
http://dx.doi.org/10.21037/tgh-23-12
_version_ 1785091354921009152
author Friedel, David
author_facet Friedel, David
author_sort Friedel, David
collection PubMed
description BACKGROUND AND OBJECTIVE: This narrative review discusses Barrett’s esophagus management in the context of perceived deficiencies or controversies. Barrett’s adenocarcinoma incidence has not clearly been impacted by Barrett’s screening and surveillance. METHODS: The following report was derived from articles using PubMed and Google searches. The search was concentrated on Barrett’s esophagus screening and management guidelines, KEY CONTENT AND FINDINGS: Comprehensive literature searches that highlight potential deficiencies or controversies regarding the current approach to Barrett’s esophagus were employed. Esophageal adenocarcinoma incidence is rapidly increasing and this malignancy usually presents in an advanced and unresectable state. This is despite the significant expenditure of resources and time in endoscopic screening for and surveillance of Barrett’s esophagus. Thus, more widespread screening for Barrett’s esophagus may be considered. In addition, there are apparent inefficiencies and precision lack in the performance of endoscopic surveillance. This relates mainly to the lack of endoscopic cues for dysplasia. On the other hand, relatively low-risk subjects have frequent screening or surveillance procedures increasing cost. Lastly, endoscopic ablation for Barrett’s with dysplasia has moderately good efficacy, especially for eradication of dysplasia, but mandates intensive post-therapy endoscopic surveillance. There is some concern for subsurface development of advanced Barrett’s lesions. Fortunately, there is intense research in improving Barrett’s esophagus diagnosis and treatment. Our narrative review will delineate deficiencies and potential measures to remedy them. CONCLUSIONS: In conclusion, screening for Barrett’s esophagus and surveillance in Barrett’s subjects have minimal established benefits, but proposed changes in screening practices and innovations in Barrett’s esophagus endoscopic surveillance and dysplasia therapy have great promise.
format Online
Article
Text
id pubmed-10432233
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104322332023-08-18 Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review Friedel, David Transl Gastroenterol Hepatol Review Article BACKGROUND AND OBJECTIVE: This narrative review discusses Barrett’s esophagus management in the context of perceived deficiencies or controversies. Barrett’s adenocarcinoma incidence has not clearly been impacted by Barrett’s screening and surveillance. METHODS: The following report was derived from articles using PubMed and Google searches. The search was concentrated on Barrett’s esophagus screening and management guidelines, KEY CONTENT AND FINDINGS: Comprehensive literature searches that highlight potential deficiencies or controversies regarding the current approach to Barrett’s esophagus were employed. Esophageal adenocarcinoma incidence is rapidly increasing and this malignancy usually presents in an advanced and unresectable state. This is despite the significant expenditure of resources and time in endoscopic screening for and surveillance of Barrett’s esophagus. Thus, more widespread screening for Barrett’s esophagus may be considered. In addition, there are apparent inefficiencies and precision lack in the performance of endoscopic surveillance. This relates mainly to the lack of endoscopic cues for dysplasia. On the other hand, relatively low-risk subjects have frequent screening or surveillance procedures increasing cost. Lastly, endoscopic ablation for Barrett’s with dysplasia has moderately good efficacy, especially for eradication of dysplasia, but mandates intensive post-therapy endoscopic surveillance. There is some concern for subsurface development of advanced Barrett’s lesions. Fortunately, there is intense research in improving Barrett’s esophagus diagnosis and treatment. Our narrative review will delineate deficiencies and potential measures to remedy them. CONCLUSIONS: In conclusion, screening for Barrett’s esophagus and surveillance in Barrett’s subjects have minimal established benefits, but proposed changes in screening practices and innovations in Barrett’s esophagus endoscopic surveillance and dysplasia therapy have great promise. AME Publishing Company 2023-06-15 /pmc/articles/PMC10432233/ /pubmed/37601742 http://dx.doi.org/10.21037/tgh-23-12 Text en 2023 Translational Gastroenterology and Hepatology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article
Friedel, David
Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title_full Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title_fullStr Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title_full_unstemmed Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title_short Unmet needs in Barret’s esophagus diagnosis and treatment: a narrative review
title_sort unmet needs in barret’s esophagus diagnosis and treatment: a narrative review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432233/
https://www.ncbi.nlm.nih.gov/pubmed/37601742
http://dx.doi.org/10.21037/tgh-23-12
work_keys_str_mv AT friedeldavid unmetneedsinbarretsesophagusdiagnosisandtreatmentanarrativereview